학술논문
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression
Document Type
Article
Author
Mauricio, Dennis; Bellone, Stefania; Mutlu, Levent; McNamara, Blair; Manavella, Diego D.; Demirkiran, Cem; Verzosa, Miguel Skyler Z.; Buza, Natalia; Hui, Pei; Hartwich, Tobias Max Philipp; Harold, Justin; Yang-Hartwich, Yang; Zipponi, Margherita; Altwerger, Gary; Ratner, Elena; Huang, Gloria S.; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Schwartz, Peter E.; Santin, Alessandro D.
Source
In Gynecologic Oncology March 2023 170:38-45
Subject
Language
ISSN
0090-8258